Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 7.74 USD -1.65% Market Closed
Market Cap: 601.8m USD

Profitability Summary

Chromadex Corp's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Chromadex Corp

Revenue
99.6m USD
Cost of Revenue
-38m USD
Gross Profit
61.6m USD
Operating Expenses
-53.9m USD
Operating Income
7.7m USD
Other Expenses
824k USD
Net Income
8.6m USD

Margins Comparison
Chromadex Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Chromadex Corp
NASDAQ:CDXC
598.5m USD
62%
8%
9%
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
56%
15%
10%
US
Thermo Fisher Scientific Inc
NYSE:TMO
162.1B USD
41%
18%
15%
US
Danaher Corp
NYSE:DHR
145.4B USD
60%
22%
16%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
53%
32%
26%
CH
Lonza Group AG
SIX:LONN
38.9B CHF
37%
18%
10%
US
Agilent Technologies Inc
NYSE:A
34.5B USD
54%
23%
18%
US
IQVIA Holdings Inc
NYSE:IQV
28.6B USD
35%
15%
9%
CN
WuXi AppTec Co Ltd
SSE:603259
204.5B CNY
42%
27%
27%
US
Mettler-Toledo International Inc
NYSE:MTD
25.1B USD
60%
29%
22%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR
44%
14%
7%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Chromadex Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Chromadex Corp
NASDAQ:CDXC
598.5m USD
23%
14%
18%
45%
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
4%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
162.1B USD
14%
7%
9%
8%
US
Danaher Corp
NYSE:DHR
145.4B USD
7%
5%
7%
6%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
12%
8%
12%
8%
CH
Lonza Group AG
SIX:LONN
38.9B CHF
7%
4%
8%
6%
US
Agilent Technologies Inc
NYSE:A
34.5B USD
19%
10%
16%
14%
US
IQVIA Holdings Inc
NYSE:IQV
28.6B USD
22%
5%
11%
8%
CN
WuXi AppTec Co Ltd
SSE:603259
204.5B CNY
20%
14%
17%
16%
US
Mettler-Toledo International Inc
NYSE:MTD
25.1B USD
-499%
26%
52%
31%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR
5%
2%
5%
4%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less